(株)アイビー化粧品の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証STD | 化学 | 4918/E01035 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2022/10/28 | 日証協 | 140,800株 | -10.43% | 600株 | -96.57% | 385,201株 | -1.86% | 1,800株 | -88.39% |
2022/10/21 | 日証協 | 157,200株 | -16.43% | 17,500株 | +503.45% | 392,501株 | -2.97% | 15,500株 | +355.88% |
2022/10/14 | 日証協 | 188,100株 | -0.69% | 2,900株 | -69.15% | 404,532株 | -0.07% | 3,400株 | -73.67% |
2022/10/07 | 日証協 | 189,400株 | +0.11% | 9,400株 | -38.16% | 404,832株 | +6.14% | 12,914株 | -56.66% |
2022/09/30 | 日証協 | 189,200株 | -1.3% | 15,200株 | +47.57% | 381,430株 | -5.48% | 29,800株 | +85.09% |
2022/09/22 | 日証協 | 191,700株 | +22.26% | 10,300株 | -71.07% | 403,534株 | +5.69% | 16,100株 | -59.17% |
2022/09/16 | 日証協 | 156,800株 | -2.85% | 35,600株 | +584.62% | 381,803株 | +0.42% | 39,431株 | +231.35% |
2022/09/09 | 日証協 | 161,400株 | -2.18% | 5,200株 | +2500% | 380,203株 | +1.22% | 11,900株 | +981.82% |
2022/09/02 | 日証協 | 165,000株 | -1.67% | 200株 | -97.18% | 375,603株 | -0.84% | 1,100株 | -91.91% |
2022/08/26 | 日証協 | 167,800株 | -0.65% | 7,100株 | +22.41% | 378,803株 | 0% | 13,600株 | +223.81% |
2022/08/19 | 日証協 | 168,900株 | -0.12% | 5,800株 | -12.12% | 378,803株 | -0.34% | 4,200株 | -51.16% |
2022/08/12 | 日証協 | 169,100株 | +2.92% | 6,600株 | -92.89% | 380,104株 | +1.5% | 8,600株 | -91.57% |
2022/08/05 | 日証協 | 164,300株 | -5.3% | 92,800株 | +27.65% | 374,504株 | -3.51% | 102,010株 | +202.42% |
2022/07/29 | 日証協 | 173,500株 | -0.91% | 72,700株 | +351.55% | 388,146株 | -0.36% | 33,731株 | +104.31% |
2022/07/22 | 日証協 | 175,100株 | -1.35% | 16,100株 | +71.28% | 389,546株 | +0.08% | 16,510株 | +70.21% |
2022/07/15 | 日証協 | 177,500株 | -4.72% | 9,400株 | -40.51% | 389,236株 | -0.43% | 9,700株 | -21.77% |
2022/07/08 | 日証協 | 186,300株 | -7.54% | 15,800株 | +9999.99% | 390,936株 | -1.86% | 12,400株 | +785.71% |
2022/07/01 | 日証協 | 201,500株 | -7.57% | 100株 | -98.98% | 398,336株 | -1.97% | 1,400株 | -86.42% |
2022/06/24 | 日証協 | 218,000株 | -5.71% | 9,800株 | +8.89% | 406,336株 | -0.75% | 10,309株 | +124.11% |
※株式分割は考慮していませんのでご注意ください。
Page Top